548 Evolution of myeloid-mediated mechanisms of immunotherapy resistance at single-cell resolution with human prostate cancer progression

Abstract

BackgroundPatients with metastatic castration-resistant prostate cancer (mCRPC) are refractory to immune checkpoint inhibitors (ICIs).1 2 Although prostate cancer is highly populated by multiple immunosuppressive myeloid cells especially after androgen deprivation...